Savara Inc. Relocates Principal Executive Offices to Langhorne, PA
Ticker: SVRA · Form: 8-K · Filed: Jan 5, 2024 · CIK: 1160308
| Field | Detail |
|---|---|
| Company | Savara Inc (SVRA) |
| Form Type | 8-K |
| Filed Date | Jan 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: corporate-governance, administrative, address-change
TL;DR
**Savara Inc. moved its main office to Pennsylvania, a minor but notable operational change.**
AI Summary
Savara Inc. filed an 8-K on January 5, 2024, to update its principal executive offices from 6836 Bee Cave Road, Building 3, Suite 201, Austin, TX 78746 to 1717 Langhorne Newtown Road, Suite 300, Langhorne, PA 19047. This change matters to investors because it indicates a significant operational shift, potentially impacting local employment, logistical costs, and overall corporate strategy, which could influence future financial performance and stock valuation.
Why It Matters
This relocation could signal a strategic shift for Savara Inc., potentially impacting operational costs, access to talent, and future business development, which are all factors that can influence the company's stock performance.
Risk Assessment
Risk Level: low — The filing primarily reports a change of address, which is a routine administrative update and does not inherently pose significant financial risk.
Analyst Insight
A smart investor would note this administrative change but recognize it's unlikely to have an immediate, direct impact on stock price. Further investigation into the strategic reasons behind the relocation might be warranted if other corporate announcements follow.
Key Players & Entities
- Savara Inc. (company) — the registrant filing the 8-K
- January 5, 2024 (date) — date of earliest event reported and filing date
- 6836 Bee Cave Road, Building 3, Suite 201, Austin, TX 78746 (address) — former principal executive offices
- 1717 Langhorne Newtown Road, Suite 300, Langhorne, PA 19047 (address) — new principal executive offices
- 001-32157 (number) — Commission File Number for Savara Inc.
FAQ
What was the specific date of the earliest event reported in this 8-K filing by Savara Inc.?
The earliest event reported by Savara Inc. in this 8-K filing occurred on January 5, 2024.
What is the new address for Savara Inc.'s principal executive offices as stated in the filing?
The new address for Savara Inc.'s principal executive offices is 1717 Langhorne Newtown Road, Suite 300, Langhorne, PA 19047.
What was Savara Inc.'s previous principal executive office address before this change?
Savara Inc.'s previous principal executive office address was 6836 Bee Cave Road, Building 3, Suite 201, Austin, TX 78746.
Under which section of the Securities Exchange Act of 1934 was this current report filed?
This current report was filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is the telephone number for Savara Inc. listed in the filing?
The telephone number for Savara Inc. listed in the filing is (512) 614-1848.
Filing Stats: 563 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-01-05 08:00:59
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SVRA The Nasdaq Global Se
Filing Documents
- d704842d8k.htm (8-K) — 25KB
- d704842dex991.htm (EX-99.1) — 37KB
- g704842ex99_1p10g1.jpg (GRAPHIC) — 350KB
- g704842ex99_1p11g1.jpg (GRAPHIC) — 411KB
- g704842ex99_1p12g1.jpg (GRAPHIC) — 324KB
- g704842ex99_1p13g1.jpg (GRAPHIC) — 333KB
- g704842ex99_1p14g1.jpg (GRAPHIC) — 323KB
- g704842ex99_1p15g1.jpg (GRAPHIC) — 245KB
- g704842ex99_1p16g1.jpg (GRAPHIC) — 230KB
- g704842ex99_1p17g1.jpg (GRAPHIC) — 300KB
- g704842ex99_1p18g1.jpg (GRAPHIC) — 323KB
- g704842ex99_1p19g1.jpg (GRAPHIC) — 262KB
- g704842ex99_1p1g1.jpg (GRAPHIC) — 280KB
- g704842ex99_1p20g1.jpg (GRAPHIC) — 281KB
- g704842ex99_1p21g1.jpg (GRAPHIC) — 387KB
- g704842ex99_1p22g1.jpg (GRAPHIC) — 362KB
- g704842ex99_1p23g1.jpg (GRAPHIC) — 324KB
- g704842ex99_1p24g1.jpg (GRAPHIC) — 297KB
- g704842ex99_1p25g1.jpg (GRAPHIC) — 378KB
- g704842ex99_1p26g1.jpg (GRAPHIC) — 305KB
- g704842ex99_1p27g1.jpg (GRAPHIC) — 439KB
- g704842ex99_1p28g1.jpg (GRAPHIC) — 320KB
- g704842ex99_1p29g1.jpg (GRAPHIC) — 283KB
- g704842ex99_1p2g1.jpg (GRAPHIC) — 592KB
- g704842ex99_1p30g1.jpg (GRAPHIC) — 211KB
- g704842ex99_1p31g1.jpg (GRAPHIC) — 331KB
- g704842ex99_1p32g1.jpg (GRAPHIC) — 203KB
- g704842ex99_1p3g1.jpg (GRAPHIC) — 140KB
- g704842ex99_1p4g1.jpg (GRAPHIC) — 331KB
- g704842ex99_1p5g1.jpg (GRAPHIC) — 281KB
- g704842ex99_1p6g1.jpg (GRAPHIC) — 322KB
- g704842ex99_1p7g1.jpg (GRAPHIC) — 349KB
- g704842ex99_1p8g1.jpg (GRAPHIC) — 307KB
- g704842ex99_1p9g1.jpg (GRAPHIC) — 374KB
- 0001193125-24-002889.txt ( ) — 14243KB
- svra-20240105.xsd (EX-101.SCH) — 3KB
- svra-20240105_lab.xml (EX-101.LAB) — 18KB
- svra-20240105_pre.xml (EX-101.PRE) — 11KB
- d704842d8k_htm.xml (XML) — 3KB
01
Item 7.01. Regulation FD Disclosure. Savara has updated its corporate presentation, which is available on the Investor Relations page of Savara's website at https://savarapharma.com/investors/events-presentations/ . A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Savara undertakes no duty or obligation to update or revise the information contained in this presentation, although it may do so from time to time. Any such updates may be made through the Investor Relations page of the Savara website, the filing of other reports or documents with the U.S. Securities and Exchange Commission (the "SEC"), press releases, or other public disclosure. The information in Item 7.01 in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Savara Corporate Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 5, 2024 SAVARA INC. a Delaware corporation By: /s/ Dave Lowrance Dave Lowrance Chief Financial & Administrative Officer